MiMedx Group Bets on Surgery Growth and Sanara Deal as Wound Care Struggles
MiMedx CFO Doug Rice said at a conference that the company is relying on growth in its surgical business and its pending Sanara MedTech acquisition to help offset a difficult year for its wound care franchise.
Why it matters — The comments highlight how MiMedx expects surgery growth and the pending deal to address challenges in wound care.